These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23400950)

  • 41. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
    Sanseviero E; O'Brien EM; Karras JR; Shabaneh TB; Aksoy BA; Xu W; Zheng C; Yin X; Xu X; Karakousis GC; Amaravadi RK; Nam B; Turk MJ; Hammerbacher J; Rubinstein MP; Schuchter LM; Mitchell TC; Liu Q; Stone EL
    Cancer Immunol Res; 2019 Aug; 7(8):1371-1380. PubMed ID: 31239316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
    Gao J; Shi LZ; Zhao H; Chen J; Xiong L; He Q; Chen T; Roszik J; Bernatchez C; Woodman SE; Chen PL; Hwu P; Allison JP; Futreal A; Wargo JA; Sharma P
    Cell; 2016 Oct; 167(2):397-404.e9. PubMed ID: 27667683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses.
    Qu Q; Zhai Z; Xu J; Li S; Chen C; Lu B
    Front Immunol; 2020; 11():634. PubMed ID: 32351508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.
    Olson BM; Jankowska-Gan E; Becker JT; Vignali DA; Burlingham WJ; McNeel DG
    J Immunol; 2012 Dec; 189(12):5590-601. PubMed ID: 23152566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
    Ichinose K; Zhang Z; Koga T; Juang YT; Kis-Tóth K; Sharpe AH; Kuchroo V; Crispín JC; Tsokos GC
    Arthritis Rheum; 2013 Mar; 65(3):764-9. PubMed ID: 23203389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTLA-4 blockade drives loss of T
    Zappasodi R; Serganova I; Cohen IJ; Maeda M; Shindo M; Senbabaoglu Y; Watson MJ; Leftin A; Maniyar R; Verma S; Lubin M; Ko M; Mane MM; Zhong H; Liu C; Ghosh A; Abu-Akeel M; Ackerstaff E; Koutcher JA; Ho PC; Delgoffe GM; Blasberg R; Wolchok JD; Merghoub T
    Nature; 2021 Mar; 591(7851):652-658. PubMed ID: 33588426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
    Liu SM; Sutherland AP; Zhang Z; Rainbow DB; Quintana FJ; Paterson AM; Sharpe AH; Oukka M; Wicker LS; Kuchroo VK
    J Immunol; 2012 Jan; 188(1):155-62. PubMed ID: 22124121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice.
    Ahern E; Harjunpää H; Barkauskas D; Allen S; Takeda K; Yagita H; Wyld D; Dougall WC; Teng MWL; Smyth MJ
    Clin Cancer Res; 2017 Oct; 23(19):5789-5801. PubMed ID: 28634284
    [No Abstract]   [Full Text] [Related]  

  • 52. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
    Sutmuller RP; van Duivenvoorde LM; van Elsas A; Schumacher TN; Wildenberg ME; Allison JP; Toes RE; Offringa R; Melief CJ
    J Exp Med; 2001 Sep; 194(6):823-32. PubMed ID: 11560997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function.
    Stumpf M; Zhou X; Chikuma S; Bluestone JA
    Eur J Immunol; 2014 Jun; 44(6):1737-46. PubMed ID: 24648182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
    Yu CR; Kim SH; Mahdi RM; Egwuagu CE
    J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-faceted inhibition of dendritic cell function by CD4
    Seitz C; Liu S; Klocke K; Joly AL; Czarnewski PV; Tibbitt CA; Parigi SM; Westerberg LS; Coquet JM; Villablanca EJ; Wing K; Andersson J
    J Autoimmun; 2019 Mar; 98():86-94. PubMed ID: 30616979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigen-specific suppression of antibody responses by T lymphocytes cytotoxic for antigen-presenting cells.
    Kagaya K; Shang H; Miyakawa Y; Fukazawa Y
    APMIS; 1994 Jun; 102(6):439-45. PubMed ID: 7520709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.
    Toussirot E; Saas P; Deschamps M; Pouthier F; Perrot L; Perruche S; Chabod J; Tiberghien P; Wendling D
    Arthritis Res Ther; 2009; 11(4):R101. PubMed ID: 19570209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epicutaneous immunization with DNP-BSA induces CD4+ CD25+ Treg cells that inhibit Tc1-mediated CS.
    Majewska-Szczepanik M; Zemelka-Wiącek M; Ptak W; Wen L; Szczepanik M
    Immunol Cell Biol; 2012 Sep; 90(8):784-95. PubMed ID: 22290507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.
    Schmidt EM; Wang CJ; Ryan GA; Clough LE; Qureshi OS; Goodall M; Abbas AK; Sharpe AH; Sansom DM; Walker LS
    J Immunol; 2009 Jan; 182(1):274-82. PubMed ID: 19109158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.